Intelligence · Clinical Pipeline
MSD Merck Sharp Pipeline
All ClinicalTrials.gov programs at MSD Merck Sharp — phase, modality, and trial IDs.
- Programs
- 50
Quick answer
MSD Merck Sharp has 50 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
-
Tuvusertib (M1774) Human Mass Balance and Absolute Bioavailability Study (DDRIVER Solid Tumors 303)
Merck Sharp and Dohme
Advanced Solid Tumors
1 trial -
Tuvusertib (M1774) in Participants with Metastatic or Locally Advanced Unresectable Solid Tumors (DDRiver Solid Tumors 301)
Merck Sharp and Dohme
Metastatic or Locally Advanced Unresectable Solid Tumors
1 trial
Frequently asked questions
How many pipeline programs does MSD Merck Sharp have?
50 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.
Data attribution: Data sources · All pipeline programs